Literature DB >> 15585736

Birth weight and subsequent cholesterol levels: exploration of the "fetal origins" hypothesis.

Rachel Huxley1, Christopher G Owen, Peter H Whincup, Derek G Cook, Sam Colman, Rory Collins.   

Abstract

CONTEXT: Inverse associations between birth weight and subsequent blood cholesterol levels have been used to support the "fetal origins" hypothesis of the relevance of fetal nutrition to adult disease.
OBJECTIVES: To perform a systematic review of the association between birth weight and total blood cholesterol levels, and to explore the impact of including unpublished results, adjusting for potential confounders. DATA SOURCES AND STUDY SELECTION: Relevant studies published by September 30, 2004, were identified through literature searches using EMBASE and MEDLINE and MeSH heading search strategy (using terms such as birth weight, intrauterine growth retardation, fetal growth retardation and cholesterol, lipoprotein, lipid). Studies that reported qualitative or quantitative estimates of the association between birth weight and total blood cholesterol, or had recorded both measures but not reported on their associations, were included. DATA EXTRACTION: A total of 79 relevant studies involving a total of 74,122 individuals were identified; 65 had reported on the direction of the association between birth weight and total blood cholesterol. Although regression coefficients were published for only 11 studies and other quantitative estimates for 3 other studies, regression coefficients (published or unpublished) were obtained for 58 studies among 68,974 individuals. DATA SYNTHESIS: Inverse associations were observed in 11 of 14 studies that had previously published quantitative estimates but in only 18 of the remaining 51 that had reported on the direction of this association (heterogeneity P = .004). Similarly, the weighted estimate for the 11 studies was -1.89 mg/dL (-0.049 mmol/L) total cholesterol per kilogram birth weight compared with -0.69 mg/dL (-0.018 mmol/L) per kilogram for 47 studies that provided unpublished regression coefficients (heterogeneity P = .009). Overall, the weighted estimate from the 58 contributing studies was -1.39 mg/dL (-0.036 mmol/L) per kilogram (95% confidence interval, -1.81 to -0.97 mg/dL [-0.047 to -0.025 mmol/L]), but there was significant heterogeneity between their separate results (P<.001). Part of this heterogeneity appears to reflect stronger associations reported from smaller studies and studies of cholesterol levels in infants.
CONCLUSION: These findings suggest that impaired fetal growth does not have effects on blood cholesterol levels that would have a material impact on vascular disease risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15585736     DOI: 10.1001/jama.292.22.2755

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  39 in total

1.  Fetal nutritional origins of adult diseases: challenges for epidemiological research.

Authors:  Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2008-11-29       Impact factor: 8.082

2.  Early-Life State-of-Residence Characteristics and Later Life Hypertension, Diabetes, and Ischemic Heart Disease.

Authors:  David H Rehkopf; Ellen A Eisen; Sepideh Modrek; Elizabeth Mokyr Horner; Benjamin Goldstein; Sadie Costello; Linda F Cantley; Martin D Slade; Mark R Cullen
Journal:  Am J Public Health       Date:  2015-06-11       Impact factor: 9.308

3.  Diagnosis and management of Silver-Russell syndrome: first international consensus statement.

Authors:  Emma L Wakeling; Frédéric Brioude; Oluwakemi Lokulo-Sodipe; Susan M O'Connell; Jennifer Salem; Jet Bliek; Ana P M Canton; Krystyna H Chrzanowska; Justin H Davies; Renuka P Dias; Béatrice Dubern; Miriam Elbracht; Eloise Giabicani; Adda Grimberg; Karen Grønskov; Anita C S Hokken-Koelega; Alexander A Jorge; Masayo Kagami; Agnes Linglart; Mohamad Maghnie; Klaus Mohnike; David Monk; Gudrun E Moore; Philip G Murray; Tsutomu Ogata; Isabelle Oliver Petit; Silvia Russo; Edith Said; Meropi Toumba; Zeynep Tümer; Gerhard Binder; Thomas Eggermann; Madeleine D Harbison; I Karen Temple; Deborah J G Mackay; Irène Netchine
Journal:  Nat Rev Endocrinol       Date:  2016-09-02       Impact factor: 43.330

4.  Perinatal inflammation induces sex-related differences in cardiovascular morbidities in mice.

Authors:  Markus Velten; Kathryn M Heyob; Loren E Wold; Lynette K Rogers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-12-06       Impact factor: 4.733

5.  Birth weight was longitudinally associated with cardiometabolic risk markers in mid-adulthood.

Authors:  Fawaz Mzayek; J Kennedy Cruickshank; Doris Amoah; Sathanur Srinivasan; Wei Chen; Gerald S Berenson
Journal:  Ann Epidemiol       Date:  2016-08-10       Impact factor: 3.797

6.  Non-communicable diseases in sub-Saharan Africa: the case for cohort studies.

Authors:  Michelle D Holmes; Shona Dalal; Jimmy Volmink; Clement A Adebamowo; Marina Njelekela; Wafaie W Fawzi; Walter C Willett; Hans-Olov Adami
Journal:  PLoS Med       Date:  2010-05-11       Impact factor: 11.069

Review 7.  Early influences on cardiovascular and renal development.

Authors:  J J Miranda Geelhoed; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2010-09-25       Impact factor: 8.082

8.  Lipid profiles in middle-aged men and women after famine exposure during gestation: the Dutch Hunger Winter Families Study.

Authors:  L H Lumey; Aryeh D Stein; Henry S Kahn; J A Romijn
Journal:  Am J Clin Nutr       Date:  2009-04-22       Impact factor: 7.045

9.  Gross placental measures and childhood growth.

Authors:  Kesha Baptiste-Roberts; Carolyn M Salafia; Wanda K Nicholson; Anne Duggan; Nae-Yuh Wang; Frederick L Brancati
Journal:  J Matern Fetal Neonatal Med       Date:  2009-01

10.  Estimated birth weight and adult cardiovascular risk factors in a developing southern Chinese population: a cross sectional study.

Authors:  C M Schooling; C Q Jiang; T H Lam; B J Cowling; S L Au Yeung; W S Zhang; K K Cheng; G M Leung
Journal:  BMC Public Health       Date:  2010-05-24       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.